Nomura Holdings »

Revance Therapeutics shares owned by Nomura Holdings

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Nomura Holdings from 13F filings

Historical chart of Nomura Holdings investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Nomura Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Nomura Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $198k 23k 8.79
2023-09-30 $258k 23k 11.47

More positions owned by Nomura Holdings

Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Dollar Tree (DLTR)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Select Sector Spdr Tr Energy Call Option (XLE)
Microsoft Corporation (MSFT)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Macy's (M)
Catalent (CTLT)
Western Digital (WDC)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Nomura Holdings

Top funds holding Revance Therapeutics

Palo Alto Investors
Vanguard Group
Franklin Resources
Jpmorgan Chase & Co
Jennison Associates
Bamco
Walleye Trading Advisors
Goldman Sachs Group
Rice Hall James & Associates
Charles Schwab Investment Management
Citadel Advisors
Wellington Management Company
D. E. Shaw & Co
HighTower Advisors
Balyasny Asset Management

View all funds holding Revance Therapeutics